Investing Profile

Geert-Jan Mulder

InvestorVC
Managing Partner at Managing Partner
forbion.comNaarden, Netherlands
Photo of Geert-Jan Mulder, Managing Partner at Forbion

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Forbion Managing Partner
$100K - $5.0M
$1.5M
19
CompanyStageDateRound SizeTotal Raised
Mariana Oncology
Series BSep 2023$180M
$250M
Co-investors: Dan Becker (Access Biotechnology), Kevin Bitterman (Atlas Venture), Josh Resnick
Complement Therapeutics
Series AApr 2023$79M
SeedFeb 2022$6M
$85M
Co-investors: Dmitrij Hristodorov (Forbion), Max Klement (BGV (BioGeneration Ventures)), Anne Horgan (Cambridge Innovation Capital)
Prilenia
Series BNov 2021$43M
Series AJun 2020$63M
$110M
AM Pharma
Series UnknownMar 2020$25M
Series FJul 2019$130M
Series CAug 2007$3M
$210M
Co-investors: Raphael Wisniewski (Andera Partners), Rémi Droller (Kurma Partners), Joël Jean-Mairet (Ysios Capital), Martijn Kleijwegt (EQT Life Sciences), Felice Verduyn - van Weegen (EQT Life Sciences), Laia Crespo (Sanofi Ventures)
Exosome Diagnostics
Series CJul 2017$30M
Series BJan 2016$16M
Series BSep 2015$18M
Series BMar 2014$27M
Series AMay 2010$20M
$110M
Co-investors: Steven Soignet (Arcus Ventures), Marco Boorsma (Forbion)
Bluebird Bio
Series DJul 2012$60M
Series CApr 2011$30M
Series BMar 2010$35M
$130M
Co-investors: Steven Gillis (ARCH Venture Partners), Robert Tepper (Third Rock Ventures), Philip Reilly (Third Rock Ventures)
Promedior
Series DMar 2012$22M
Series CMar 2010$12M
$48M
Co-investors: Amir Nashat (Polaris Partners)
Amakem
Series ASep 2011$25M
$25M